Other studies have shown that CXCR4 overexpression of mesenchymal stem cells does not improve the homing and therapeutic potential of these cells in acute kidney injury, suggesting that the type and severity of kidney injury may influence the homing of modified stem cells [18]. This evidence concerns the gene CXCR4 and kidney injury.